These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. DuPont HL; Hornick RB; Dawkins AT; Heiner GG; Fabrikant IB; Wisseman CL; Woodward TE J Infect Dis; 1973 Sep; 128(3):340-4. PubMed ID: 4199563 [No Abstract] [Full Text] [Related]
7. New assay of protective activity of Rocky Mountain spotted fever vaccines. Anacker RL; Smith RF; Mann RE; Hamilton MA J Clin Microbiol; 1976 Sep; 4(3):309-11. PubMed ID: 823177 [TBL] [Abstract][Full Text] [Related]
8. Comparison of three rocky mountain spotted fever vaccines. Kenyon RH; Sammons LS; Pedersen CE J Clin Microbiol; 1975 Oct; 2(4):300-4. PubMed ID: 810494 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a killed Rocky Mountain spotted fever vaccine in cynomolgus monkeys. Gonder JC; Kenyon RH; Pedersen CE J Clin Microbiol; 1979 Nov; 10(5):719-23. PubMed ID: 120877 [TBL] [Abstract][Full Text] [Related]
10. Surface protein Adr2 of Rickettsia rickettsii induced protective immunity against Rocky Mountain spotted fever in C3H/HeN mice. Gong W; Xiong X; Qi Y; Jiao J; Duan C; Wen B Vaccine; 2014 Apr; 32(18):2027-33. PubMed ID: 24582636 [TBL] [Abstract][Full Text] [Related]
11. Preparation of vaccines for Rocky Mountain spotted fever from rickettsiae propagated in cell culture. Kenyon RH; Acree WM; Wright GG; Melchior FW J Infect Dis; 1972 Feb; 125(2):146-52. PubMed ID: 4621411 [No Abstract] [Full Text] [Related]